Tianjin Chase Sun Pharmaceutical Co Ltd (300026) — Cash Flow Reinvestment Rate
Tianjin Chase Sun Pharmaceutical Co Ltd (300026) has a Cash Flow Reinvestment Rate of 0.14x as of September 2025, reinvesting CN¥21.58 Million (capex CN¥21.58 Million ) from operating cash flow of CN¥153.30 Million. Explore 300026 capital expenditure intensity to see what proportion of operating cash flow is directed to capital expenditures.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Tianjin Chase Sun Pharmaceutical Co Ltd Cash Flow Reinvestment Rate (2006–2024)
Historical reinvestment intensity for Tianjin Chase Sun Pharmaceutical Co Ltd across 19 annual periods. Also explore 300026 total assets for the complete picture of this company's asset base.
Annual Cash Flow Reinvestment Rate for Tianjin Chase Sun Pharmaceutical Co Ltd (2006–2024)
Year-by-year capital reinvestment analysis for Tianjin Chase Sun Pharmaceutical Co Ltd. For live market cap and broader valuation context, see Tianjin Chase Sun Pharmaceutical Co Ltd market capitalisation.
| Year | Reinvestment Rate | Total Reinvested (CNY) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2024 | 0.23x | CN¥199.91 Million | CN¥852.24 Million | CN¥193.12 Million | ▼ -52.1% |
| 2023 | 0.49x | CN¥750.04 Million | CN¥1.53 Billion | CN¥347.12 Million | ▼ -75.6% |
| 2022 | 2.01x | CN¥1.50 Billion | CN¥745.35 Million | CN¥770.27 Million | ▲ +13.8% |
| 2021 | 1.77x | CN¥692.19 Million | CN¥391.60 Million | CN¥677.45 Million | ▼ -38.7% |
| 2020 | 2.88x | CN¥566.93 Million | CN¥196.66 Million | CN¥563.78 Million | ▼ -5.9% |
| 2019 | 3.06x | CN¥662.25 Million | CN¥216.10 Million | CN¥591.01 Million | ▲ +302.4% |
| 2018 | 0.76x | CN¥295.61 Million | CN¥388.19 Million | CN¥294.89 Million | ▲ +13.6% |
| 2017 | 0.67x | CN¥497.73 Million | CN¥742.38 Million | CN¥383.34 Million | ▼ -70.6% |
| 2016 | 2.28x | CN¥1.02 Billion | CN¥448.08 Million | CN¥415.52 Million | ▲ +1.9% |
| 2015 | 2.24x | CN¥270.51 Million | CN¥121.00 Million | CN¥223.35 Million | ▲ +87.9% |
| 2014 | 1.19x | CN¥178.37 Million | CN¥149.94 Million | CN¥178.37 Million | ▲ +59.4% |
| 2013 | 0.75x | CN¥107.20 Million | CN¥143.60 Million | CN¥107.20 Million | ▼ -48.6% |
| 2012 | 1.45x | CN¥221.17 Million | CN¥152.21 Million | CN¥221.17 Million | ▼ -80.3% |
| 2011 | 7.37x | CN¥262.51 Million | CN¥35.64 Million | CN¥262.51 Million | ▲ +201.7% |
| 2010 | 2.44x | CN¥112.90 Million | CN¥46.25 Million | CN¥112.90 Million | ▲ +561.8% |
| 2009 | 0.37x | CN¥49.82 Million | CN¥135.06 Million | CN¥49.82 Million | ▼ -40.6% |
| 2008 | 0.62x | CN¥48.28 Million | CN¥77.74 Million | CN¥48.28 Million | ▲ +661.3% |
| 2007 | 0.08x | CN¥5.87 Million | CN¥72.01 Million | CN¥5.87 Million | ▼ -96.8% |
| 2006 | 2.54x | CN¥3.12 Million | CN¥1.22 Million | CN¥3.12 Million | — |